Stock Price
64.08
Daily Change
0.62 0.98%
Monthly
-5.93%
Yearly
-19.15%
Q3 Forecast
63.66

Peers Price Chg Day Year Date
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Essilor 259.60 -0.60 -0.23% 22.74% Sep/06
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
GRIFOLS 12.30 0.02 0.16% 32.17% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
Smith & Nephew 1,416.00 6.00 0.43% 18.15% Sep/05
Sonova Holding 239.50 1.90 0.80% -19.82% Sep/05
UCB 206.90 2.30 1.12% 28.99% Sep/05

Indexes Price Day Year Date
CH20 12371 -12.90 -0.10% 3.88% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Alcon AG traded at 64.08 this Friday September 5th, increasing 0.62 or 0.98 percent since the previous trading session. Looking back, over the last four weeks, Alcon AG gained 5.93 percent. Over the last 12 months, its price fell by 19.15 percent. Looking ahead, we forecast Alcon AG to be priced at 63.66 by the end of this quarter and at 62.40 in one year, according to Trading Economics global macro models projections and analysts expectations.